<?xml version="1.0" encoding="UTF-8"?>
<p>Neurodegenerative disorders are currently incurable, and the available therapies only control symptoms or prolong the disease’s growth. EOs have been proposed as an underlying preventive and treatment strategies for anti-ageing and neurodegenerative disorders [
 <xref rid="B15-molecules-26-01107" ref-type="bibr">15</xref>]. Many studies have reported the potential of various EOs and their components to exhibit neuroprotective effects [
 <xref rid="B16-molecules-26-01107" ref-type="bibr">16</xref>,
 <xref rid="B17-molecules-26-01107" ref-type="bibr">17</xref>]. 
 <italic>Cinnamomum</italic> sp. [
 <xref rid="B18-molecules-26-01107" ref-type="bibr">18</xref>,
 <xref rid="B19-molecules-26-01107" ref-type="bibr">19</xref>], 
 <italic>Salvia</italic> sp. [
 <xref rid="B20-molecules-26-01107" ref-type="bibr">20</xref>,
 <xref rid="B21-molecules-26-01107" ref-type="bibr">21</xref>], 
 <italic>Polygonum</italic> sp. [
 <xref rid="B22-molecules-26-01107" ref-type="bibr">22</xref>], 
 <italic>Lavandula</italic> sp. [
 <xref rid="B23-molecules-26-01107" ref-type="bibr">23</xref>,
 <xref rid="B24-molecules-26-01107" ref-type="bibr">24</xref>], 
 <italic>Citrus</italic> sp. [
 <xref rid="B25-molecules-26-01107" ref-type="bibr">25</xref>], 
 <italic>Artemisia</italic> sp. [
 <xref rid="B26-molecules-26-01107" ref-type="bibr">26</xref>,
 <xref rid="B27-molecules-26-01107" ref-type="bibr">27</xref>], and 
 <italic>Zingiber</italic> sp. [
 <xref rid="B28-molecules-26-01107" ref-type="bibr">28</xref>] are among the most widely explored species for evaluating the effectiveness of EOs and its respective components in age-related neurodegenerative disorders. The four most commonly studied age-related neurodegenerative diseases are Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS).
</p>
